• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Cancer-Targeting Compound 1 Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5754250

Cancer-Targeting Compound 1, extracted from patent WO 2008021331 A2, is used in the research of hormone-related cancer. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Cancer-Targeting Compound 1, Inhibitor
Full Product Name
Cancer-Targeting Compound 1
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
299.35
Solubility
<1mg/ml refers to the product slightly soluble or insoluble
Formula
C15H13N3O2S
SMILES
N#CC1=CC=C(C2=CSC(N3C(OCC3(C)C)=O)=N2)C=C1
CAS Number
1007581-62-5
Target & IC50
Others

Product References and Citations for Cancer-Targeting Compound 1, inhibitor

Thomas, Joseph, et al. OXAZOLIDONE DERIVATIVES AS PR MODULATORS. WO 2008021331 A2.
Thomas, Joseph, et al. OXAZOLIDONE DERIVATIVES AS PR MODULATORS. WO 2008021331 A2.

Other Notes

Small volumes of Cancer-Targeting Compound 1, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Cancer-Targeting Compound 1 purchase

MBS5754250 is an inhibitor targeting Cancer-Targeting Compound 1.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000